The US Bankruptcy Court gave an order approving the sale of substantially all the assets of Infinity Pharmaceuticals, Inc. on December 8, 2023. The debtor has been authorized to sell its certain assets to Deerfield Healthcare Innovations Fund III, L.P. for a purchase price of $1 million in cash pursuant to the asset purchase agreement dated December 8, 2023. Under the terms of the asset purchase agreement, the buyer has made an earnest money deposit of $0.1 million upon the execution of the agreement.

The buyer is represented by Peter Knight and Mark Wood of Katten Muchin Rosenman LLP as its legal advisors.